| Elucidation of Exosome Migration Across the Blood–Brain Barrier Model In Vitro CC Chen, L Liu, F Ma, CW Wong, XE Guo, JV Chacko, HP Farhoodi, ... Cellular and molecular bioengineering 9, 509-529, 2016 | 482 | 2016 |
| Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders M Riazifar, MR Mohammadi, EJ Pone, A Yeri, C Lasser, AI Segaliny, ... ACS nano 13 (6), 6670-6688, 2019 | 445 | 2019 |
| Interleukin‐34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment AI Ségaliny, A Mohamadi, B Dizier, A Lokajczyk, R Brion, R Lanel, ... International journal of cancer 137 (1), 73-85, 2015 | 201 | 2015 |
| Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers AI Ségaliny, M Tellez-Gabriel, MF Heymann, D Heymann Journal of bone oncology 4 (1), 1-12, 2015 | 200 | 2015 |
| Functional TCR T cell screening using single-cell droplet microfluidics AI Segaliny, G Li, L Kong, C Ren, X Chen, JK Wang, D Baltimore, G Wu, ... Lab on a Chip 18 (24), 3733-3749, 2018 | 170 | 2018 |
| The 5A apolipoprotein AI mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro F Tabet, AT Remaley, AI Segaliny, J Millet, L Yan, S Nakhla, PJ Barter, ... Arteriosclerosis, thrombosis, and vascular biology 30 (2), 246-252, 2010 | 144 | 2010 |
| Mechanoresponsive stem cells to target cancer metastases through biophysical cues L Liu, SX Zhang, W Liao, HP Farhoodi, CW Wong, CC Chen, AI Ségaliny, ... Science translational medicine 9 (400), eaan2966, 2017 | 111 | 2017 |
| Syndecan-1 regulates the biological activities of interleukin-34 AI Segaliny, R Brion, E Mortier, M Maillasson, M Cherel, Y Jacques, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1853 (5), 1010-1021, 2015 | 101 | 2015 |
| Preclinical mouse models of osteosarcoma Ö Uluçkan, A Segaliny, S Botter, JM Santiago, AJ Mutsaers BoneKEy reports 4, 2015 | 52 | 2015 |
| IL-34 and M-CSF form a novel heteromeric cytokine and regulate the M-CSF receptor activation and localization AI Ségaliny, R Brion, B Brulin, M Maillasson, C Charrier, S Téletchéa, ... Cytokine 76 (2), 170-181, 2015 | 51 | 2015 |
| Bone morphogenetic protein 2 and transforming growth factor β1 inhibit the expression of the proinflammatory cytokine IL-34 in rheumatoid arthritis synovial fibroblasts M Chemel, R Brion, AI Segaliny, A Lamora, C Charrier, B Brulin, ... The American journal of pathology 187 (1), 156-162, 2017 | 46 | 2017 |
| Combinatorial targeting of cancer bone metastasis using mRNA engineered stem cells AI Segaliny, JL Cheng, HP Farhoodi, M Toledano, CC Yu, B Tierra, ... EBioMedicine 45, 39-57, 2019 | 20 | 2019 |
| Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders. ACS Nano. 2019; 13 (6): 6670–88 M Riazifar, MR Mohammadi, EJ Pone, A Yeri, C Lässer, AI Segaliny, ... | 19 | |
| A high throughput bispecific antibody discovery pipeline AI Segaliny, J Jayaraman, X Chen, J Chong, R Luxon, A Fung, Q Fu, ... Communications biology 6 (1), 380, 2023 | 15 | 2023 |
| Optimization of a syngeneic murine model of bone metastasis HP Farhoodi, AI Segaliny, ZW Wagoner, JL Cheng, L Liu, W Zhao Journal of Bone Oncology 23, 100298, 2020 | 14 | 2020 |
| Anti IL-34 antibodies D Heymann, A Segaliny, R Brion US Patent 10,703,813, 2020 | 3 | 2020 |
| BMP-2 and TGF-β1 inhibit the expression of the pro-inflammatory cytokine IL-34 in rheumatoid arthritis synovial fibroblasts M Chemel, R Brion, A Segaliny, A Lamora, C Charrier, B Brulin, ... American Journal of Pathology 187 (1), 156–162, 2017 | 2 | 2017 |
| 1155 ABS-101, a novel class of tumor-activated CD3xTROP2 T cell engager for solid tumors Y Zhou, X Ma, X Jiang, R Rivera, R Bettman, JY Chen, TT Aye, A Navarro, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |
| Anti-cd3 constructs and uses thereof Y Shang, AI Segaliny, MA Xiaoya, X Jiang, G Wu US Patent App. 18/570,578, 2024 | | 2024 |
| 10,368 first dates: Microfluidic T cell matchmaking SH Au Science Translational Medicine 10 (468), eaav9144, 2018 | | 2018 |
